Application
Western blot analysis of anti-COL9A1 Antibody (Center) in 293 cell line lysates (35ug/lane). COL9A1(arrow) was detected using the purified Pab (1:60dilution).Application
Formalin-fixed and paraffin-embedded human breast carcinoma tissue reacted with COL9A1 antibody (Center) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | COL9A1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:50~100 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | COL9A1 Collagen alpha-1(IX) chain |
|---|---|
| Molecular Weight(MW) | 91869 Da |
| Function | Structural component of hyaline cartilage and vitreous of the eye |
| Tissue Specificity | This COL9A1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 435~464 amino acids from the Center region of human COL9A1. |
| Cellular Localization | Secreted, extracellular space, extracellular matrix (By similarity) |
| Entrez Gene | 1297 |
|---|
Application
Western blot analysis of anti-COL9A1 Antibody (Center) in 293 cell line lysates (35ug/lane). COL9A1(arrow) was detected using the purified Pab (1:60dilution).
Application
Formalin-fixed and paraffin-embedded human breast carcinoma tissue reacted with COL9A1 antibody (Center) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:50~100 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
